Summary:
RILA GLOBAL CONSULTING is revolutionizing pharmacovigilance by integrating social listening and secure, real-world research to uncover safety signals, patient needs, and actionable insights beyond traditional reporting methods. As a trusted partner to leading pharmaceutical companies, RILA offers pharmacovigilance-ready social data monitoring, robust data security (SOC 2 Type II, ISO 27001), and full compliance with GVP, GDPR, and HIPAA standards. Their AI-enhanced workflows support efficient case triage and medical review, while their global research capabilities span both qualitative and quantitative methodologies. RILA’s evidence-based findings have been accepted at major medical congresses, demonstrating their impact across Medical Affairs, Market Research, and beyond. With multilingual global teams and seamless collaboration across pharma functions, RILA delivers compliant, strategic insights throughout the drug lifecycle.
Transforming Pharmacovigilance Through Social Listening and Secure Research
In the age of real-world data, pharmacovigilance is no longer limited to traditional reporting channels. Social media, online forums, and patient communities have become powerful ecosystems for surfacing safety signals, uncovering unmet needs, and elevating the voice of the patient. At the forefront of this evolution is RILA GLOBAL CONSULTING, a certified and trusted partner to leading pharmaceutical companies—delivering pharmacovigilance-ready social listening and secure, global insights.
Meeting the Highest Standards in Pharmacovigilance
RILA GLOBAL CONSULTING recently passed a rigorous pharmacovigilance audit conducted by one of the world’s largest pharmaceutical companies, reinforcing the agency’s commitment to compliance, data integrity, and operational excellence. The firm’s SOPs are fully aligned with GVP Module VI, GDPR, and HIPAA, ensuring that all safety-relevant content—including Adverse Events (AEs), Product Quality Complaints (PQCs), Medication Errors, and Special Situations—is handled with the utmost care and adherence to global safety guidelines.
Adding to its credibility, RILA holds SOC 2 Type II and ISO 27001 certifications, offering partners peace of mind when it comes to data security, privacy, and regulatory compliance. With built-in workflows for ICSR-ready case triage, AI-enhanced AE detection, and medical review, RILA is uniquely positioned to support pharmacovigilance teams with scalable and compliant processes.
Beyond Social Listening: A Full-Service Research Partner
While social listening remains a cornerstone of RILA’s pharmacovigilance services, the agency is equally skilled in traditional market research methodologies. From qualitative interviews and focus groups to quantitative surveys and segmentation studies, RILA blends methodologies to deliver well-rounded insights that inform medical, commercial, and public affairs strategies.
This multi-method approach allows RILA to support stakeholders across the entire product lifecycle, from early pipeline research to post-launch lifecycle management. Whether it's understanding treatment journeys, evaluating perceptions of risk, or tracking therapeutic trends, RILA’s insights drive actionable strategy at every step.
Research That Reaches the World Stage
What truly sets RILA apart is its ability to translate social and market data into scientific research accepted at global medical congresses. The agency partners with Medical Affairs, Real-World Evidence (RWE), and Insights teams to produce research submitted to leading conferences such as:
- ASCO (American Society of Clinical Oncology)
- ESMO (European Society for Medical Oncology)
- San Antonio Breast Cancer Symposium (SABCS)
RILA’s work has resulted in accepted abstracts, oral presentations, and posters, showcasing how real-world digital data—when analyzed correctly—can generate credible, evidence-based findings worthy of global recognition.
Cross-Functional Support, Global Impact
RILA collaborates across a diverse range of functions, including Medical Affairs, Market Research & Insights, Inflammation & Immunology, Rare Diseases, Vaccines, Commercial, R&D, Public Affairs, and Corporate Communications. The agency's global team operates in multiple languages, ensuring localized yet compliant monitoring and reporting.
In addition, as a certified vendor under established Omnichannel Solutions groups, RILA offers internal licensing coverage and streamlined workflows for large pharma clients—minimizing friction and maximizing value.
Pharmacovigilance is evolving, and RILA GLOBAL CONSULTING is helping to lead the charge—where real-time social data, secure workflows, and evidence-backed research converge. If you’re looking for a partner who understands both the science and compliance of safety monitoring, and the art of insight generation, RILA is the team to trust. Fortune500 recommendations available upon request.
Learn more at www.rilaglobalconsulting.com